Forbes(@Forbes):Shares of biopharmaceutical company Kodiak Sciences Inc. were up more than 150% in the hour after the opening bell Monday morning after promising late-stage trials for a pair of experimental eye drugs that could be the firm’s first products to ever go to market. Read more:

Forbes

@Forbes

Joined November 2009

4.6K Following 20.3M Followers

Forbes@Forbes

2026.09.28 17:24

Shares of biopharmaceutical company Kodiak Sciences Inc. were up more than 150% in the hour after the opening bell Monday morning after promising late-stage trials for a pair of experimental eye drugs that could be the firm’s first products to ever go to market. Read more: